Skip to main content

Advertisement

Log in

Development and Initial Feedback About a Human Papillomavirus (HPV) Vaccine Comic Book for Adolescents

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) vaccination rates do not meet the Healthy People 2020 objective of 80 % coverage among adolescent females. We describe the development and initial feedback about an HPV vaccine comic book for young adolescents. The comic book is one component of a multilevel intervention to improve HPV vaccination rates among adolescents. Parents suggested and provided input into the development of a HPV vaccine comic book. Following the development of the comic book, we conducted a pilot study to obtain initial feedback about the comic book among parents (n = 20) and their adolescents ages 9 to 14 (n = 17) recruited from a community-based organization. Parents completed a pre-post test including items addressing HPV knowledge, HPV vaccine attitudes, and about the content of the comic book. Adolescents completed a brief interview after reading the comic book. After reading the comic book, HPV knowledge improved (2.7 to 4.6 correct answers on a 0–5 scale; p < 0.01) and more positive attitudes toward HPV vaccination (p < 0.05) were reported among parents. Parents confirmed that the comic book’s content was acceptable and adolescents liked the story, found it easy to read, and thought the comic book was a good way to learn about being healthy. Parents provided valuable information in the development of a theoretically-based comic book and the comic book appears to be an acceptable format for providing HPV vaccine information to adolescents. Future research will include the comic book in an intervention study to improve HPV vaccination rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819

    Article  CAS  PubMed  Google Scholar 

  2. Weinstock H, Berman S, Cates W Jr (2004) Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 36(1):6–10

    Article  PubMed  Google Scholar 

  3. Hariri S, Unger ER, Sternberg M et al (2011) Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. J Infect Dis 204(4):566–573

    Article  PubMed  Google Scholar 

  4. Garland SM, Steben M, Sings HL et al (2009) Natural history of genital warts: analysis of the placebo arm of two randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 199(6):805–814

    Article  PubMed  Google Scholar 

  5. Gillison ML, Broutian T, Pickard RK et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307(7):693–703

    Article  CAS  PubMed  Google Scholar 

  6. Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113(10 Suppl):3036–3046

    Article  PubMed  Google Scholar 

  7. Watson M, Saraiya M, Ahmed F et al (2008) Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 113(10 Supple):2841–2854

    Article  PubMed  Google Scholar 

  8. Centers for Disease Control and Prevention (CDC) (2010) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. Morb Mortal Wkly Rep 59:630–632

    Google Scholar 

  9. Centers for Disease Control and Prevention (CDC) (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. Morb Mortal Wkly Rep 60:1705–1708

    Google Scholar 

  10. Centers for Disease Control and Prevention (CDC) (2010) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR. Morb Mortal Wkly Rep 59:626–629

    Google Scholar 

  11. United States Department of Health and Human Services. Healthy People 2020. 2010: Retrieved June 20, 2013, from http://www.healthypeople.gov/2020/about/default.aspx

  12. Centers for Disease Control and Prevention (CDC) (2012) National and state vaccination coverage among adolescents aged 13–17 years–United States, 2012. MMWR Morb Mortal Wkly Rep 62:685–693

    Google Scholar 

  13. Darden PM, Thompson DM, Roberts JR et al (2013) Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010. Pediatrics 131(4):645–651

    Article  PubMed  Google Scholar 

  14. Fisher WA (2012) Understanding human papillomavirus vaccine uptake. Vaccine 30(Suppl 5):F149–F156

    Article  CAS  PubMed  Google Scholar 

  15. Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT (2013) Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health 103(8):1419–1427

    Article  PubMed Central  PubMed  Google Scholar 

  16. Singhal A, Rogers EM (2002) A theoretical agenda for entertainment-education. Commun Theory 12(2):117–135

    Google Scholar 

  17. Hinyard LJ, Kreuter MW (2007) Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview. Health Educ Behav 34(5):777–792

    Article  PubMed  Google Scholar 

  18. Chaiken S (1980) Heuristic versus systematic information-processing and the use of source versus message cues in persuasion. J Pers Soc Psychol 39(5):752–766

    Article  Google Scholar 

  19. Petty RE, Cacioppo J (1986) The elaboration likelihood model of persuasion. In: Berkowitz L (ed) Advances in experimental social psychology. Academic, San Diego, pp 123–205

    Google Scholar 

  20. Green MC, Brock TC (2000) The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol 79(5):701–721

    Article  CAS  PubMed  Google Scholar 

  21. Kovacs F, Oliver-Frontera M, Plana MN, Rouela A, Muriel A, Gestoso M (2011) Improving schoolchildren’s knowledge of methods for the prevention and management of low back pain: a cluster randomized controlled trial. Spine 36(8):E505–E512

    Article  PubMed  Google Scholar 

  22. Liebman AK, Juarez PM, Leyva C, Corona A (2007) A pilot program using promotoras de salud to educate farm worker families about the risk from pesticide exposure. J Agromedicine 12(2):33–43

    Article  PubMed  Google Scholar 

  23. Prokhorov AV, Hudmon KS, Marani SK et al (2013) Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). Addict Behav 38(1):1485–1492

    Article  PubMed  Google Scholar 

  24. Putnam GL, Yanagisako KL (1985) Skin cancer comic book: evaluation of a public educational vehicle. J Audiov Media Med 8(1):22–25

    CAS  PubMed  Google Scholar 

  25. Sinha I, Patel A, Kim FS, Maccorkle ML, Watkins JF (2011) Comic books can educate children about burn safety in developing countries. J Burn Care Res 32(4):e112–e117

    Article  PubMed  Google Scholar 

  26. Vigano O (1983) Comic books carry health messages to rural children in Honduras. Dev Dig 21(2):114–117

    CAS  PubMed  Google Scholar 

  27. Camey RN, Levin JR (2002) Pictorial illustrations still improve students’ learning from text. Educ Psychol 14(1):5–26

    Google Scholar 

  28. Gambrell LB, Jawitz PB (1993) Mental imagery, text illustrations and children’s story comprehension and recall. Read Res Q 28:264–276

    Article  Google Scholar 

  29. Hosler J, Boomer KB (2011) Are comic books an effective way to engage nonmajors in learning and appreciating science? CBE Life Sci Educ 10(3):309–317

    Article  PubMed Central  PubMed  Google Scholar 

  30. Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179–211

    Article  Google Scholar 

  31. Glanz K, Rimer BK, Lewis FM (2002) Health behavior and health education: theory, research, and practice, 3rd edn. Jossey-Bass, San Francisco

    Google Scholar 

  32. Gerend MA, Shepherd JE (2012) Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med 44(2):171–180

    Article  PubMed Central  PubMed  Google Scholar 

  33. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED (2009) Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 27(30):3945–3952

    Article  PubMed Central  PubMed  Google Scholar 

  34. Ciy-Data.com (2013) Greater Hilltop (Hilltop) neighborhood in Columbus, Ohio (OH), 43223, 43204, 43229 detailed profile. Accessed on December 18, 2013, http://www.city-data.com/neighborhood/Greater-Hilltop-Columbus-OH.html

  35. Kepka D, Coronado GD, Rodriguez HP, Thompson B (2011) Evaluation of a radionovela to promote HPV vaccine awareness and knowledge among Hispanic parents. J Community Health 36(6):957–965

    Article  PubMed Central  PubMed  Google Scholar 

  36. Kepka DL, Coronado GD, Rodriguez HP, Thompson B (2012) Development of a radionovela to promote HPV vaccine awareness and knowledge among Latino parents. Public Health Rep 127(1):130–138

    PubMed Central  PubMed  Google Scholar 

  37. Hughes CC, Jones AL, Feemster KA, Fiks AG (2011) HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 11:74

    Article  PubMed Central  PubMed  Google Scholar 

  38. Lipstein EA, Brinkman WB, Britto MT (2012) What is known about parents’ treatment decisions? A narrative review of pediatric decision making. Med Decis Making 32(2):246–258

    Article  PubMed Central  PubMed  Google Scholar 

  39. Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK (2013) Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 40(2):130–135

    PubMed  Google Scholar 

  40. Flagg EW, Schwartz R, Weinstock H (2013) Prevalence of anogenital warts among participants in private health plans in the United States, 2003–2010: potential impact of human papillomavirus vaccination. Am J Public Health 103(8):1428–1435

    Article  PubMed Central  PubMed  Google Scholar 

  41. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK (2011) The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination program. Sex Transm Infect 87(7):544–547

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Cancer Institute at the National Institutes of Health (R21 CA12803).

PLR, MTR, and EDP have received research grants from Merck Sharp & Dohme Corp., but none have received honoraria or consulting fees from this company. These funds were not used to support this research study. The remaining authors have no conflicts to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mira L. Katz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katz, M.L., Oldach, B.R., Goodwin, J. et al. Development and Initial Feedback About a Human Papillomavirus (HPV) Vaccine Comic Book for Adolescents. J Canc Educ 29, 318–324 (2014). https://doi.org/10.1007/s13187-013-0604-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-013-0604-8

Keywords

Navigation